Steroid 5β-reductase (AKR1D1): Purification and characterization
Author:
Penning Trevor M.
Reference21 articles.
1. Development of nonsteroidal anti-inflammatory drug analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: potential antineoplastic agents that work independently of cyclooxygenase isozymes;Bauman;Molecular Pharmacology,2005
2. Mechanism-based inhibition of human steroid 5α-reductase by finasteride: Enzyme-catalyzed formation of NADP−dihydrofinasteride, a potent bisubstrate analog inhibitor;Bull;Journal of the American Chemical Society,1996
3. An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3α-HSD, type 5 17β-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies
4. Substrate specificity and inhibitor analyses of human steroid 5β-reductase (AKR1D1);Chen;Steroids,2011
5. In-depth dissection of the P133R mutation in steroid 5β-reductase (AKR1D1): A molecular basis of bile acid deficiency;Chen;Biochemistry,2015